Koen Van Herck

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. ncbi request reprint A review of the long-term protection after hepatitis A and B vaccination
    Pierre Van Damme
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department of Epidemiology and Social Medicine, University of Antwerp, Belgium
    Travel Med Infect Dis 5:79-84. 2007
  2. pmc Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa
    Lukas L Widmer
    University of Zurich Centre for Travel Medicine, WHO Collaborating Centre for Travellers Health, Hirschengraben 84, 8001 Zurich, Switzerland
    BMC Infect Dis 10:279. 2010
  3. doi request reprint Prevention of viral hepatitis (B and C) reassessed
    Koen Van Herck
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    Best Pract Res Clin Gastroenterol 22:1009-29. 2008
  4. ncbi request reprint Prevention of hepatitis A by Havrix: a review
    Koen Van Herck
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for the Prevention and Control of Viral Hepatitis, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    Expert Rev Vaccines 4:459-71. 2005
  5. ncbi request reprint Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course
    Koen Van Herck
    Centre for the Evaluation of Vaccination, University of Antwerp, Belgium
    J Med Virol 72:194-6. 2004
  6. ncbi request reprint Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults
    K Van Herck
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Unit of Epidemiology and Social Medicine, University of Antwerp Campus Drie Eiken, Wilrijk, Belgium
    Travel Med Infect Dis 5:171-5. 2007
  7. pmc Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance
    K Van Herck
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department Epidemiology and Social Medicine, University of Antwerp, Campus Drie Eiken, Antwerp, Belgium
    Sex Transm Infect 83:426-32. 2007
  8. doi request reprint Benefits of early hepatitis B immunization programs for newborns and infants
    Koen Van Herck
    WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Vaccine, and Infectious Disease Institute, University of Antwerp, Belgium
    Pediatr Infect Dis J 27:861-9. 2008
  9. ncbi request reprint Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey
    Koen Van Herck
    WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Unit of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium
    J Travel Med 11:3-8. 2004
  10. ncbi request reprint A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine
    Pierre Van Damme
    Unit of Epidemiology and Social Medicine, Centre for the Evaluation of Vaccination, WHO Collaborating Centre for the Prevention and Control of Viral Hepatitis, University of Antwerp, Campus 3 Eiken, Wilrijk, Belgium
    Expert Rev Vaccines 3:249-67. 2004

Detail Information

Publications25

  1. ncbi request reprint A review of the long-term protection after hepatitis A and B vaccination
    Pierre Van Damme
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department of Epidemiology and Social Medicine, University of Antwerp, Belgium
    Travel Med Infect Dis 5:79-84. 2007
    ....
  2. pmc Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa
    Lukas L Widmer
    University of Zurich Centre for Travel Medicine, WHO Collaborating Centre for Travellers Health, Hirschengraben 84, 8001 Zurich, Switzerland
    BMC Infect Dis 10:279. 2010
    ....
  3. doi request reprint Prevention of viral hepatitis (B and C) reassessed
    Koen Van Herck
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    Best Pract Res Clin Gastroenterol 22:1009-29. 2008
    ..Despite important efforts, transmission in injecting drug users is increasing...
  4. ncbi request reprint Prevention of hepatitis A by Havrix: a review
    Koen Van Herck
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for the Prevention and Control of Viral Hepatitis, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    Expert Rev Vaccines 4:459-71. 2005
    ..In view of this, current regulatory recommendations for the use of hepatitis A vaccines are reviewed and possible future strategies identified...
  5. ncbi request reprint Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course
    Koen Van Herck
    Centre for the Evaluation of Vaccination, University of Antwerp, Belgium
    J Med Virol 72:194-6. 2004
    ..This study shows a substantial immune response to re-exposure to hepatitis A antigen after 12 years, which occurs rapidly to ensure protection within the average incubation period of hepatitis A virus...
  6. ncbi request reprint Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults
    K Van Herck
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Unit of Epidemiology and Social Medicine, University of Antwerp Campus Drie Eiken, Wilrijk, Belgium
    Travel Med Infect Dis 5:171-5. 2007
    ..Hepatitis A and B infections are prevalent worldwide and cause significant morbidity and mortality. A combined vaccine providing dual protection against hepatitis A and B is available (Twinrix, GlaxoSmithKline Biologicals)...
  7. pmc Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance
    K Van Herck
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department Epidemiology and Social Medicine, University of Antwerp, Campus Drie Eiken, Antwerp, Belgium
    Sex Transm Infect 83:426-32. 2007
    ..Vaccination is an important tool in hepatitis B prevention. However, several vaccine doses are required to induce long-term protection. Several at-risk groups have difficulties in adhering to the standard vaccination schedule...
  8. doi request reprint Benefits of early hepatitis B immunization programs for newborns and infants
    Koen Van Herck
    WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Vaccine, and Infectious Disease Institute, University of Antwerp, Belgium
    Pediatr Infect Dis J 27:861-9. 2008
    ....
  9. ncbi request reprint Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey
    Koen Van Herck
    WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Unit of Epidemiology and Social Medicine, University of Antwerp, Antwerp, Belgium
    J Travel Med 11:3-8. 2004
    ..This paper describes the methods used everywhere, and results from the European airports...
  10. ncbi request reprint A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine
    Pierre Van Damme
    Unit of Epidemiology and Social Medicine, Centre for the Evaluation of Vaccination, WHO Collaborating Centre for the Prevention and Control of Viral Hepatitis, University of Antwerp, Campus 3 Eiken, Wilrijk, Belgium
    Expert Rev Vaccines 3:249-67. 2004
    ..This paper provides a critical review of clinical data on the efficacy, immunogenicity and tolerability of the combined vaccine, with particular focus on the clinical benefits of dual vaccination...
  11. pmc Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study
    Tessa Braeckman
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    BMJ 345:e4752. 2012
    ..To evaluate the effectiveness of rotavirus vaccination among young children in Belgium...
  12. doi request reprint Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memory
    Tessa Braeckman
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerpen Wilrijk, Belgium
    Vaccine 30:4757-61. 2012
    ..We studied the persistence of vaccine-induced anti-HBs antibodies and the robustness of the HBsAg-specific immune memory in this population, 18-20 years after the first vaccine dose...
  13. ncbi request reprint Do we need hepatitis A booster vaccinations?
    Pierre A Van Damme
    Center for the Evaluation of Vaccination, Epidemiology and Social Medicine, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk, Belgium
    J Travel Med 11:179-80. 2004
  14. doi request reprint Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years
    Koen Van Herck
    Centre for the Evaluation of Vaccination WHO Collaborating Centre, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    J Med Virol 83:1885-91. 2011
    ..No difference in long-term antibody persistence was observed between the two primary vaccination schedules, reinforcing the potential for flexibility in the timing of the second primary vaccine dose...
  15. doi request reprint Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine
    Koen Van Herck
    Vaccine and Infectious Disease Institute WHO Collaborating Centre, Centre for the Evaluation of Vaccination, Antwerpen, Belgium
    Hum Vaccin Immunother 8:323-7. 2012
    ..This communication provides additional information on antibody persistence up to Year 17 from two of the longest follow-up studies [NCT00289757/NCT00291876]...
  16. pmc Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003
    Surbhi Malhotra-Kumar
    University of Antwerp, Antwerp, Belgium
    Emerg Infect Dis 11:939-42. 2005
    ..We also report one of the largest collections of telithromycin-resistant isolates...
  17. doi request reprint Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008
    Carine Asnong
    School Health Center of the Province of Antwerp, Antwerp, Belgium
    Pediatr Infect Dis J 30:343-5. 2011
    ..Not only belief issues but difficulties to access the regular vaccination program also seem to be the main reason...
  18. doi request reprint Rotavirus vaccines in Belgium: policy and impact
    Tessa Braeckman
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    Pediatr Infect Dis J 30:S21-4. 2011
    ..Shortly after introduction, a nation-wide recommendation was issued and despite the fact that both rotavirus vaccines are offered through partial reimbursement, vaccine uptake has already reached a high level (at least 90%)...
  19. ncbi request reprint Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study
    Koen Van Herck
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis Epidemiology and Social Medicine, University of Antwerp, Universiteitsplein 1, B 2610 Antwerp, Belgium
    J Travel Med 10:75-8. 2003
    ....
  20. ncbi request reprint Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)
    Marie Van der Wielen
    Department of Epidemiology and Social Medicine, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    Vaccine 21:2412-7. 2003
    ..These data confirm waning of vaccine-induced antibody levels and suggest pertussis resurgence during adolescence and young adulthood. These results support a pertussis booster vaccination policy for adolescents and adults...
  21. ncbi request reprint Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study
    Surbhi Malhotra-Kumar
    Department of Medical Microbiology, University of Antwerp, Belgium
    Lancet 369:482-90. 2007
    ..We used the macrolides azithromycin and clarithromycin to investigate the direct effect of antibiotic exposure on resistance in the oral streptococcal flora of healthy volunteers...
  22. ncbi request reprint Effect of hepatitis A vaccination programs
    Pierre Van Damme
    JAMA 294:246-8. 2005
  23. ncbi request reprint Hepatitis A vaccine
    Koen Van Herck
    N Engl J Med 350:2211-2; author reply 2211-2. 2004
  24. ncbi request reprint Combined hepatitis A and B vaccine in elderly
    Pierre Van Damme
    Vaccine 22:303-4. 2004
  25. ncbi request reprint Rapid protection and vaccination against hepatitis A for travellers
    Bradley A Connor
    The New York Center for Travel and Tropical Medicine, New York, NY 10021, USA
    BioDrugs 17:19-21. 2003